World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 109 514 475 313 284 496 52655
Medicine 109 5705 5355 3068 2842 500 52798

Michael M. Lederman publications per year

The chart shows the history of publications by Michael M. Lederman between 1966 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michael M. Lederman published across 60 years, from 1966 to 2025, averaging 8.8 papers a year. Output peaked at 28 publications in 2010. 20 of the 526 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1966 to 2025. Vertical axis: number of publications, 0 to 28. Peak 28 publications in 2010. 1966: 1 publication 1967: 1 publication 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 1 publication 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 1 publication 1981: 4 publications 1982: 3 publications 1983: 7 publications 1984: 4 publications 1985: 5 publications 1986: 7 publications 1987: 9 publications 1988: 3 publications 1989: 4 publications 1990: 2 publications 1991: 1 publication 1992: 4 publications 1993: 1 publication 1994: 3 publications 1995: 8 publications 1996: 6 publications 1997: 6 publications 1998: 12 publications 1999: 14 publications 2000: 13 publications 2001: 19 publications 2002: 17 publications 2003: 24 publications 2004: 12 publications 2005: 11 publications 2006: 16 publications 2007: 14 publications 2008: 13 publications 2009: 13 publications 2010: 28 publications 2011: 16 publications 2012: 19 publications 2013: 23 publications 2014: 25 publications 2015: 17 publications 2016: 22 publications 2017: 12 publications 2018: 13 publications 2019: 13 publications 2020: 20 publications 2021: 19 publications 2022: 6 publications 2023: 14 publications 2024: 12 publications 2025: 8 publications
1966 2025

526 publications in total across all disciplines

View publications per year as a table
Michael M. Lederman: publications per year, 1966 to 2025
Year Publications
1966 1
1967 1
1968 0
1969 0
1970 0
1971 1
1972 0
1973 0
1974 0
1975 0
1976 0
1977 0
1978 0
1979 0
1980 1
1981 4
1982 3
1983 7
1984 4
1985 5
1986 7
1987 9
1988 3
1989 4
1990 2
1991 1
1992 4
1993 1
1994 3
1995 8
1996 6
1997 6
1998 12
1999 14
2000 13
2001 19
2002 17
2003 24
2004 12
2005 11
2006 16
2007 14
2008 13
2009 13
2010 28
2011 16
2012 19
2013 23
2014 25
2015 17
2016 22
2017 12
2018 13
2019 13
2020 20
2021 19
2022 6
2023 14
2024 12
2025 8
Total 526
Download as CSV

Michael M. Lederman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael M. Lederman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 492–501 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 496 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30 496
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Michael M. Lederman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael M. Lederman sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 108–109 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 109 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23 109
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Michael M. Lederman is affiliated with Case Western Reserve University in the United States. Their research spans multiple disciplines within medicine, particularly focusing on immunology, microbiology, and infectious diseases.

The primary fields of study for Michael M. Lederman include:

  • Medicine
  • Immunology and Microbiology

Subfields of their work cover:

  • Infectious Diseases
  • Virology
  • Immunology
  • Emergency Medicine
  • Epidemiology

Research topics central to Michael M. Lederman's work include:

  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research
  • Atherosclerosis and Cardiovascular Diseases

Their notable recent publications include:

  • SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy, 2020, published in EBioMedicine
  • Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy, 2023, published in Cell Host & Microbe
  • Translocated microbiome composition determines immunological outcome in treated HIV infection, 2021, published in Cell
  • Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop, 2020, published in Pathogens and Immunity
  • Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus, 2021, published in Clinical Infectious Diseases

Michael M. Lederman frequently collaborates with the following researchers:

  • Michael L. Freeman
  • Steven G. Deeks
  • Nicholas Funderburg
  • Daniela Moïsi
  • Peter W. Hunt

Their publications often appear in these journals and venues:

  • Pathogens and Immunity
  • UNC Libraries
  • Frontiers in Immunology
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases

Michael M. Lederman has been recognized by professional organizations with distinctions such as:

  • Fellow of the American Association for the Advancement of Science (AAAS), 2011
  • Member of the Association of American Physicians

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher

  • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells

    Michael R. Betts;Martha C. Nason;Sadie M. West;Stephen C. De Rosa

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism

    Ivan Vujkovic-Cvijin;Richard M. Dunham;Shoko Iwai;Michael C. Maher

  • Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection

    Wei Jiang;Michael M. Lederman;Peter Hunt;Scott F. Sieg

  • HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

    Sergio Serrano-Villar;Talia Sainz;Sulggi A. Lee;Peter W. Hunt

  • A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia

    James J. Goedert;Craig M. Kessler;Louis M. Aledort;Robert J. Biggar

  • Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

    Michael Marcel Lederman;Elizabeth Connick;Alan Landay;Daniel R. Kuritzkes

  • Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment

    Allan R. Tenorio;Yu Zheng;Ronald J. Bosch;Supriya Krishnan

  • Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication

    Miguel E Quiñones-Mateu;Michael M Lederman;Zhimin Feng;Bikram Chakraborty

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

    Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive

  • A potential role for interleukin-7 in T-cell homeostasis

    Terry J. Fry;Elizabeth Connick;Judith Falloon;Michael Marcel Lederman

  • Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5

    Michael M Lederman;Ronald S Veazey;Robin Ewart Offord;Donald E Mosier

  • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

    Craig W. Hendrix;Ann C. Collier;Michael Marcel Lederman;Dominique Schols

  • Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2

    Nicholas Funderburg;Michael M. Lederman;Zhimin Feng;Michael G. Drage

  • Impaired Cell-Mediated Immunity in Patients with Classic Hemophilia

    Michael M. Lederman;Oscar D. Ratnoff;James J. Scillian;Paul K. Jones

  • Inadequate T follicular cell help impairs B cell immunity during HIV infection

    Rafael A. Cubas;Joseph C. Mudd;Anne Laure Savoye;Matthieu Perreau

  • Perforin Expression Directly Ex Vivo by HIV-Specific CD8 + T-Cells Is a Correlate of HIV Elite Control

    Adam R. Hersperger;Florencia Pereyra;Martha Nason;Korey R. Demers

  • Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

    Benigno Rodríguez;Ajay K. Sethi;Vinay K. Cheruvu;Wilma Mackay

  • IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.

    Irini Sereti;Richard M. Dunham;John Spritzler;Evgenia Aga

  • Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients.

    R. A. Salata;M. M. Lederman;D. M. Shlaes;M. R. Jacobs

Frequent Co-Authors

Benigno Rodriguez
Benigno Rodriguez Case Western Reserve University
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Nicholas T. Funderburg
Nicholas T. Funderburg The Ohio State University
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Peter W. Hunt
Peter W. Hunt University of California, San Francisco
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Grace A. McComsey
Grace A. McComsey Case Western Reserve University
Ronald J. Bosch
Ronald J. Bosch Harvard University
Clifford V. Harding
Clifford V. Harding Case Western Reserve University
Daniel C. Douek
Daniel C. Douek National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related degrees can open up diverse career opportunities in healthcare and research. Many students pivot to advanced nursing roles after foundational studies, making programs like the fnp to acnp pathway a popular choice for expanding clinical expertise.

Accelerated programs offer a fast-track route for students seeking to enter the field swiftly. The accelerated nurse practitioner program is ideal for those with previous healthcare experience aiming for advanced practice roles without spending years in school.

For individuals new to nursing, the online ABSN programs for non nurses provide accessible pathways to obtain a Bachelor of Science in Nursing, which can be foundational for immunology-related healthcare careers.

Additionally, if entry requirements are a concern, researching the easiest accelerated nursing programs can help prospective students find programs that balance quality education with manageable admissions criteria.

Best Scientists Citing Michael M. Lederman

Trending Scientists

Recently Published Articles